Purified CM15 was analysed by RP-HPLC on an analytical C-18 Zorbax (150 × 4.4 mm) column using gradient elution with the above mentioned eluent A and B (flow rate was 1 mL/min, gradient was 5-100 B%, 20 min, UV detection at 220 nm).
Peptide characterization
Purified CM15 was analysed by RP-HPLC on an analytical C-18 Zorbax (150 × 4.4 mm) column using gradient elution with the above mentioned eluent A and B (flow rate was 1 mL/min, gradient was 5-100 B%, 20 min, UV detection at 220 nm).
Molecular mass of the peptide was determined by using a Bruker Esquire 3000+ ESI mass spectrometer. Peptide samples were dissolved in a mixture of acetonitrile/water = 1/1 (v/v) containing 0.1% acetic acid and introduced by a syringe pump with a flow rate of 10 μL/min . C-terminus of the peptides was amidated.
a Z: net charge at neutral pH. Calculated by the number of (K+R)-(E+D). Positive charge at the N-terminus increases Z by 1 unit.
Computational details
To support the experimental investigations with a molecular level insight into the potential interactions underlying the experienced conformational transitions, quantum chemical calculations were performed. All theoretical computations were conducted using the Gaussian 09 (G09) software package 1 . Graphical representation of the structures were created using Pymol (The PyMol Molecular Graphics System, DeLano Scientific, Palo Alto, CA).
To investigate interaction of CM15 in helical conformation with the studied negatively charged compounds, initial models were built as follows. Helical starting structure of CM15 was taken from an NMR experiment. 2 All drug and dye molecules (suramin, pamoic acid, cromolyn, Congo red, trypan blue) were built using their solution phase, deprotonated forms, where the sulfonate and carboxylate groups consequently possess a negative charge. Initial structures of these compounds were optimized at the semi-empirical level, using the PM3MM method. PM3MM was developed from PM3 to include molecular mechanics correction for amide linkage present in peptides. 3 The semi-empirical approach was chosen as it provides fast and efficient insight into the molecular level interactions with reasonable accuracy, without the cumbersome parametrization procedure required for in depth molecular dynamics simulations, a study beyond our current focus. Furthermore, the small molecule-peptide complexes are large molecular systems, up to 405 atoms, consequently preventing efficient use of higher quantum chemical methods, such as ab initio or density functional theory techniques.
All complexes were optimized starting from 3 different relative positions of the CM15 helix and the addressed negatively charged compound, requiring a total of 15 different calculations.
These all resulted in optimized structures except two positions for suramin and one for trypan blue complexes. The latter ones were subject of several optimization attempts, but failed to reach full convergence. Presented structures were chosen from the pool of three different binding modes based on their relative energies as well as on the quantity and quality of the intermolecular salt-bridges, hydrogen bonds, and stacking interactions. Supplementary Table 5 Disorder prediction results for various proteins found experimentally to be affected by cromolyn. The percentage of residues involved in predicted disordered regions of proteins is based on the corresponding MobiDB consensus score (http://mobidb.bio.unipd.it/).
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Ligand:CM15 molar ratio Stacking, Edgeedge a : Number of interactions found.
Congo red
D h P.d.
Pamoic acid
D h P.d. 1:2 - - - - - - - - 1
Supplementary Table 7
Assigned intermolecular interactions for the lowest energy complexes of the investigated small molecule-CM15 systems. The most stable complex of Congo red and CM15. D: The most stable complex of cromolyn and CM15. E: The most stable complex of pamoic acid and CM15.
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